These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 15666359)

  • 1. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
    Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
    Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer.
    Kuniyasu H; Chihara Y; Takahashi T
    Oncol Rep; 2003; 10(2):445-8. PubMed ID: 12579287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphoterin induction in prostatic stromal cells by androgen deprivation is associated with metastatic prostate cancer.
    Kuniyasu H; Chihara Y; Kondo H; Ohmori H; Ukai R
    Oncol Rep; 2003; 10(6):1863-8. PubMed ID: 14534709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. V domain of RAGE interacts with AGEs on prostate carcinoma cells.
    Allmen EU; Koch M; Fritz G; Legler DF
    Prostate; 2008 May; 68(7):748-58. PubMed ID: 18302220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects between amphoterin and advanced glycation end products on colon cancer cells.
    Kuniyasu H; Chihara Y; Kondo H
    Int J Cancer; 2003 May; 104(6):722-7. PubMed ID: 12640679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of serotonin receptors and role of serotonin in human prostate cancer tissue and cell lines.
    Dizeyi N; Bjartell A; Nilsson E; Hansson J; Gadaleanu V; Cross N; Abrahamsson PA
    Prostate; 2004 May; 59(3):328-36. PubMed ID: 15042609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of AR associated protein 55 (ARA55) and androgen receptor in prostate cancer.
    Miyoshi Y; Ishiguro H; Uemura H; Fujinami K; Miyamoto H; Miyoshi Y; Kitamura H; Kubota Y
    Prostate; 2003 Sep; 56(4):280-6. PubMed ID: 12858356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental expression of receptor for advanced glycation end products (RAGE), amphoterin and sulfoglucuronyl (HNK-1) carbohydrate in mouse cerebellum and their role in neurite outgrowth and cell migration.
    Chou DK; Zhang J; Smith FI; McCaffery P; Jungalwala FB
    J Neurochem; 2004 Sep; 90(6):1389-401. PubMed ID: 15341523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of GSPE on RAGE expression induced by advanced glycation end products in endothelial cells.
    Zhang FL; Gao HQ; Shen L
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):434-40. PubMed ID: 18049312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of receptor for advanced glycation end products (RAGE) and MMP-9 in human pancreatic cancer cells.
    Takada M; Hirata K; Ajiki T; Suzuki Y; Kuroda Y
    Hepatogastroenterology; 2004; 51(58):928-30. PubMed ID: 15239215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
    Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
    Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer.
    Kuniyasu H; Oue N; Wakikawa A; Shigeishi H; Matsutani N; Kuraoka K; Ito R; Yokozaki H; Yasui W
    J Pathol; 2002 Feb; 196(2):163-70. PubMed ID: 11793367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.
    Kobayashi T; Shimizu Y; Terada N; Yamasaki T; Nakamura E; Toda Y; Nishiyama H; Kamoto T; Ogawa O; Inoue T
    Prostate; 2010 Jun; 70(8):866-74. PubMed ID: 20127734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of receptor for advanced glycation end products (RAGE) in human biliary cancer cells.
    Hirata K; Takada M; Suzuki Y; Kuroda Y
    Hepatogastroenterology; 2003; 50(53):1205-7. PubMed ID: 14571699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The significance of LMO2 expression in the progression of prostate cancer.
    Ma S; Guan XY; Beh PS; Wong KY; Chan YP; Yuen HF; Vielkind J; Chan KW
    J Pathol; 2007 Feb; 211(3):278-85. PubMed ID: 17167821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells.
    Ma W; Lee SE; Guo J; Qu W; Hudson BI; Schmidt AM; Barile GR
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1355-61. PubMed ID: 17325184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of RAGE expression inhibits colorectal cancer cell invasion and suppresses angiogenesis in vitro and in vivo.
    Liang H; Zhong Y; Zhou S; Peng L
    Cancer Lett; 2011 Dec; 313(1):91-8. PubMed ID: 21945853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.
    Harashima A; Yamamoto Y; Cheng C; Tsuneyama K; Myint KM; Takeuchi A; Yoshimura K; Li H; Watanabe T; Takasawa S; Okamoto H; Yonekura H; Yamamoto H
    Biochem J; 2006 May; 396(1):109-15. PubMed ID: 16503878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal transducer and activator of transcription-6 (STAT6) is a constitutively expressed survival factor in human prostate cancer.
    Das S; Roth CP; Wasson LM; Vishwanatha JK
    Prostate; 2007 Oct; 67(14):1550-64. PubMed ID: 17705178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for advanced glycation end products and age-related macular degeneration.
    Howes KA; Liu Y; Dunaief JL; Milam A; Frederick JM; Marks A; Baehr W
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3713-20. PubMed ID: 15452081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.